Ablating caspase-2 protein expression similarly as blocking its catalytic function resulted in reduced caspase-3 processing and PARP-1 cleavage after GO- and calicheamicin treatment in AML cells further supporting a role for caspase-2 in GO-induced apoptotic signaling. The gene discussed is CASP3; the disease is acute myeloid leukemia.